H. Nida Sen
National Institutes of Health
OphthalmologyInternal medicineSurgeryPathologyDermatologyRetrospective cohort studyAdverse effectImmunologyUveitisInflammationVisual acuityDiseaseAutoimmune retinopathyAutoimmunityRetinalPanuveitisIn patientClinical trialMedicineBiologyImmune system
210Publications
36H-index
3,200Citations
Publications 218
Newest
#1Mehmet Yakin (NIH: National Institutes of Health)H-Index: 7
#2Natasha Kesav (NIH: National Institutes of Health)H-Index: 1
Last. H. Nida Sen (NIH: National Institutes of Health)H-Index: 36
view all 6 authors...
Abstract Purpose To report the prevalence of QuantiFERON-TB Gold (QFT-G) positivity among uveitis patients compared to general population and to evaluate the differences in clinical features of uveitis. Design Retrospective cohort study. Methods:Setting Institutional. Patient Population 418 consecutive new uveitis patients, regardless of clinical suspicion, were tested for QFT-G. Observation Procedures Demographics, TB risk factors, clinical characteristics of uveitis were collected. Main Outcom...
Source
#1LeAnne Young (NIH: National Institutes of Health)H-Index: 1
#2Shanda Finnigan (NIH: National Institutes of Health)H-Index: 2
Last. Elad SharonH-Index: 25
view all 7 authors...
Background null Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation. However, less is known about adverse effects of these drugs in the eye. null Methods null Two adverse event databases were retrospectively reviewed. The two databases consisted of a routine adverse event database and a serious adverse event database of expeditiously submitted reports. Patients with any malignancy ...
1 CitationsSource
#1Vrushali Vinay Agashe (NIH: National Institutes of Health)
#2Jung W Lee (NIH: National Institutes of Health)H-Index: 1
Last. H. Nida Sen (NIH: National Institutes of Health)H-Index: 36
view all 5 authors...
#1Sunil Bellur (GW: George Washington University)
#2Haig Pakhchanian (GW: George Washington University)H-Index: 4
Last. H. Nida Sen (NIH: National Institutes of Health)H-Index: 36
view all 6 authors...
#1David Josip Grasic (NIH: National Institutes of Health)
#2Wijak Kongwattananon (NIH: National Institutes of Health)
Last. Shilpa Kodati (NIH: National Institutes of Health)H-Index: 5
view all 0 authors...
#1Wijak Kongwattananon (King Chulalongkorn Memorial Hospital)
#2Aman Kumar (NIH: National Institutes of Health)
Last. Shilpa Kodati (NIH: National Institutes of Health)H-Index: 5
view all 4 authors...
#1Aman Kumar (NIH: National Institutes of Health)
#2Pulak Ranjan Nath (NIH: National Institutes of Health)H-Index: 8
Last. H. Nida Sen (NIH: National Institutes of Health)H-Index: 36
view all 7 authors...
#1Masumi G Asahi (GW: George Washington University)H-Index: 3
#2Haig Pakhchanian (GW: George Washington University)H-Index: 4
Last. Shilpa Kodati (NIH: National Institutes of Health)H-Index: 5
view all 7 authors...
#1LeAnne Young (NIH: National Institutes of Health)H-Index: 1
#2Jongwoo Kim (NIH: National Institutes of Health)
Last. H. Nida Sen (NIH: National Institutes of Health)H-Index: 36
view all 10 authors...
#2Camasamudram Vijayasarathy (NIH: National Institutes of Health)H-Index: 27
#3Catherine A Cukras (NIH: National Institutes of Health)H-Index: 24
Last. Paul A. Sieving (UC Davis: University of California, Davis)H-Index: 74
view all 8 authors...
This study explored systemic immune changes in 11 subjects with X-linked retinoschisis (XLRS) in a Phase I/IIa AAV8-RS1 gene therapy trial (www.ClinicalTrials.gov NCT02317887). Immune cell proportions and serum analytes were compared to 12 healthy male controls. At pre-dosing baseline the mean CD4/CD8 ratio of XLRS subjects was elevated. CD11c+ myeloid dendritic cells (DCs) and serum EGF level were decreased, while CD123+ plasmacytoid DCs and serum IFN-γ and TNF-α were increased, indicating that...
4 CitationsSource